On July 1st, Dimitri Krainc, MD, PhD, will join Northwestern University as Professor of Neurology and the new Chairman for the Ken and Ruth Davee Department of Neurology within the Feinberg School of Medicine. Dr. Krainc, a native of Slovenia, has spent the past 21 years at Harvard Medical School where his research has had a transformative impact in the area of neurodegenerative diseases. While at Harvard, Dr. Krainc was an Associate Professor of Neurology, and the Director of a research laboratory at the MassGeneral Institute for Neurodegenerative Disorders (MIND).
Dr. Krainc completed Medical School training at Zagreb Medical School. Following Med School, Dr. Krainc completed research training at Harvard Medical School, later completing a Neurology residency and Movement Disorders fellowship at Massachusetts General Hospital and Brigham & Women’s Hospital, respectively.
Dr. Krainc has become a world-renowned neurologist and neuroscientist throughout his career. His research has sought to define key molecular pathways in the causes of neurodegeneration in order to develop therapies for Huntington’s, Parkinson’s, and related diseases. Dr. Krainc was recently named a 2013 Massachusetts General Hospital Research Scholar, a program that provides five years of unrestricted funding to give innovative investigators the flexibility to pursue projects that may lead in unexpected directions.
“I am extremely honored to lead one of the nation’s premier departments of neurology and I very much look forward to working with my new colleagues,” Krainc said. “This position also carries great responsibility to seek new treatments for many neurological disorders that remain incurable, and to prepare our medical students and residents for the future of neurology and neuroscience.”
Dr. Krainc will be assuming the administrative responsibilities as Chair of Neurology, which were previously held by Dr. John ‘Jack’ Kessler. Dr. Kessler has returned full time to his laboratory research and remains on the faculty of Northwestern University.